Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- City of Hope
- Nature Careers
- Harvard University
- Nanyang Technological University
- University of British Columbia
- University of Maryland, Baltimore
- University of Oslo
- IBMC
- Keio University
- Life and Health Sciences Research Institute (ICVS), from the School of Medicine (EM) of the University of Minho
- Northeastern University
- RMIT UNIVERSITY
- RMIT University
- SUNY University at Buffalo
- The Francis Crick Institute;
- The University of British Columbia (UBC)
- UNIVERSITY OF MELBOURNE
- UNIVERSITY OF THE SUNSHINE COAST - UNISC
- Universidad de Cantabria
- Universidade de Coimbra
- University of California, San Francisco
- University of Colorado
- University of Glasgow
- University of Glasgow;
- University of Michigan - Ann Arbor
- University of Sydney
- VIB
- 17 more »
- « less
-
Field
-
genomics, transcriptomics, and epigenomics with mechanistic studies using in vitro and in vivo models to dissect B-ALL and related hematologic malignancies. The lab also studies normal hematopoietic stem
-
of morphology, developmental biology, evolution, stem cell biology, genetics (incl. population), genomics, bioinformatics and conservation. Together, we possess the skills and technical know-how to accelerate
-
dynamics, disease mechanisms, or drug response using in vitro or ex vivo systems. The candidate will collaborate with neuroscientists, stem cell researchers, and pharmacologists to integrate their devices
-
neurodegenerative diseases. 5. Oncomechanobiology: this area focuses on mechanobiological basis of development, stem cells, and cancer, with the aim to discover new pathways of intervention in pathological conditions
-
#00841101 – Requisition #38035 Job Summary: Nature of Work CellSight , the Ocular Stem Cell and Regeneration Research Program at the Department of Ophthalmology at the University of Colorado, Anschutz Medical
-
immune cells. Significantly, the AHR can regulate melanogenesis and inflammation, has important roles in tumorigenesis (e.g. invasion, metastasis, cancer stem-cell development), and is implicated in drug
-
000 individuals in UK. As part of a wider strategy to develop a deep human experimental medicines platform, this project aims to mainly focus on using novel human in vitro platforms using IBD gut stem
-
experience in mammalian cell culture, organoid culture and analysis, and stem cell biology. Strong skills in molecular biology, next-generation sequencing, bioinformatics, general microscopy and confocal
-
disease. This ambitious project focuses on the creation and validation of innovative preclinical models — including primary neuronal cultures, neurons derived from induced pluripotent stem cells (iPSCs
-
Hope. To accelerate the development of new therapies, we leverage City of Hope’s unique in-house GMP manufacturing capabilities for cell therapy (CAR-T cells, stem cells, etc.), monoclonal antibodies